RxDoctor Payments Data

Timothy Taylor, APRN

Nurse Practitioner · Ashland, KYNPI 1457812539

Payments from drug & device makers

$1,945in general payments, 2019–2025

Across 144 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$883
  • Otsuka America Pharmaceutical, Inc.$373
  • Sunovion Pharmaceuticals Inc.$209
  • Bausch Health US, LLC$57
  • Alkermes, Inc.$55
  • Vanda Pharmaceuticals Inc.$54
  • plus $314 from 10 others

What the payments were for

  • Food & beverage$1,945100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,945 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$26,596
Medicare patients
63
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate17$141,058
RexultiBrexpiprazole28$44,141
Abilify MaintenaAripiprazole11$30,523
VraylarCariprazine Hcl14$19,483
XanaxAlprazolam13$13,692
TrintellixVortioxetine Hydrobromide11$9,400
SavellaMilnacipran Hcl11$5,275
Aripiprazole54$3,670
Quetiapine Fumarate206$3,342
Buspirone Hcl226$2,477
Mirtazapine210$2,226
Clonazepam255$1,949
Duloxetine Hcl103$1,603
Vilazodone Hcl14$1,307
Venlafaxine Hcl ErVenlafaxine Hcl82$1,281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$47$141,05817 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$373$74,66439 claims
AbbVieVraylar, Savella$883$24,75825 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$39$9,40011 claims
Almatica Pharma LLCSertraline Hcl$16$1,108155 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →